When did OptimizeRx report Q4 2024 earnings?

OptimizeRx (OPRX) reported Q4 2024 earnings on March 12, 2025 before market open.

What were OptimizeRx's Q4 2024 revenue and EPS?

OptimizeRx reported revenue of $32.3M and diluted EPS of $0.30 for Q4 2024.

Did OptimizeRx beat estimates in Q4 2024?

Revenue beat the consensus estimate of $18.8M by $13.5M. EPS beat the consensus estimate of $0.25 by $0.05.

Where can I find OptimizeRx's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001213900-25-025576) directly on SEC EDGAR. The filing index links above go to sec.gov.

OptimizeRx OPRX Q4 2024 Annual earnings

Reported March 12, 2025 · Before market open

Revenue$32.3MBeat by $13.5M Diluted EPS$0.30Beat by $0.05

Revenue estimate$18.8M

EPS estimate$0.25

Next report

Aug 6, 2026 (In 3 weeks)

Revenue estimate$20.2M

EPS estimate$0.11

Financials

Q4 2024

Income statement

See full

Revenue$32.3M+13.9%

Gross profit$22.0M+23.4%

Net income-$78.0K+98.1%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$13.4M-3.4%

Total debt$33.2M-9.9%

Total equity$117.0M-7.6%

Total assets$171.2M-6.7%

Cash flow

See full

Operating cash flow$198.0K+103%

CapEx$17.0K+240%

Free cash flow$181.0K+103%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$89.53M-65.5%

Enterprise value$109.34M-61.3%

P/S1.6×-2.0×

Profitability

See full

Gross margin40.3%-19.7pp

Net margin-36.7%+35.7pp

FCF margin8.7%—

Returns & leverage

See full

Return on equity-16.5%+3.8pp

Debt / equity0.3×0.0×

Current ratio2.9×-0.1×

Versus estimates

Revenue

Q1 2026$19.8MBeat by $1.1M Q4 2025$32.2MBeat by $1.3M Q3 2025$26.1MMiss by $4.8M Q2 2025$29.2MBeat by $5.4M Q1 2025$21.9MBeat by $3.2M

Q4 2024$32.3MBeat by $13.5M

Diluted EPS

Q1 2026$0.14Beat by $0.13 Q4 2025$0.51Beat by $0.28 Q3 2025$0.20Beat by $0.17 Q2 2025$0.24Beat by $0.21 Q1 2025$0.08Beat by $0.19

Q4 2024$0.30Beat by $0.05

Ask the moment OptimizeRx reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did OptimizeRx report Q4 2024 earnings?: OptimizeRx (OPRX) reported Q4 2024 earnings on March 12, 2025 before market open.
What were OptimizeRx's Q4 2024 revenue and EPS?: OptimizeRx reported revenue of $32.3M and diluted EPS of $0.30 for Q4 2024.
Did OptimizeRx beat estimates in Q4 2024?: Revenue beat the consensus estimate of $18.8M by $13.5M. EPS beat the consensus estimate of $0.25 by $0.05.
Where can I find OptimizeRx's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001213900-25-025576) directly on SEC EDGAR. The filing index links above go to sec.gov.